Review · United States
Epitalon
Reviewed on
Approval and product status
No FDA-approved epitalon drug product
Similar names do not mean that products have the same evidence. Epitalon, epitalon acetate, and older pineal extracts such as epithalamin are not automatically interchangeable evidence objects.
What was measured in people?
- Health results · Unclear
- FDA found no studies establishing insomnia outcomes for the nominated epitalon substances and route.
- Body changes · Limited
- Melatonin and cell-line findings are indirect and do not establish patient benefit.
A change in a hormone or body signal does not by itself prove a health benefit.
Important limits
This tool is not an independent medical review. It does not recommend treatment.
A claim about longer life needs long-term results in people, not only laboratory mechanisms. This guide provides no injectable, sleep-treatment, or anti-aging regimen.
Still unknown: Changes in cells grown in a laboratory do not establish slower aging, longer life, cancer prevention, or improved health in people. Evidence from epithalamin cannot be reassigned to epitalon.
This record cannot check a package, seller, batch, or personal treatment. It does not provide sport clearance.
Products in this review
These are selected records, not every product or form.
No product label record is included here. That is not a separate approval decision. Read the status and sources above.
What the research shows
Laboratory work has reported telomere-related effects in human cell lines. Telomeres are protective ends of chromosomes. FDA's current review found melatonin-related information but no clinical insomnia studies using the nominated substances by the proposed route.
Read all Epitalon fact checksSources used in this review
A source may support some statements, not all of them. Use the links above or this review to see what each source supports.
Show 3 sources
- FDA briefing document for epitalon-related bulk drug substances
U.S. Food and Drug Administration · FDA review · 2026
Source accessed
- Epitalon and telomere length in human cell lines
PubMed · Biogerontology · Preclinical · 2025
Source accessed
- July 2026 Pharmacy Compounding Advisory Committee meeting
U.S. Food and Drug Administration · Regulatory · 2026
Source accessed